ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 52 filers reported holding ENTELLUS MED INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $464,000 | +32.2% | 19,031 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $351,000 | -1.4% | 19,031 | -11.6% | 0.00% | 0.0% |
| Q2 2017 | $356,000 | +51.5% | 21,517 | +26.4% | 0.00% | – |
| Q1 2017 | $235,000 | -19.5% | 17,017 | +10.4% | 0.00% | -100.0% |
| Q4 2016 | $292,000 | -16.8% | 15,417 | -2.5% | 0.00% | 0.0% |
| Q3 2016 | $351,000 | +22.3% | 15,817 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $287,000 | +36.7% | 15,717 | +36.0% | 0.00% | – |
| Q1 2016 | $210,000 | +25.0% | 11,557 | +15.9% | 0.00% | – |
| Q4 2015 | $168,000 | -5.6% | 9,970 | +1.0% | 0.00% | – |
| Q3 2015 | $178,000 | -30.2% | 9,870 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $255,000 | +20.3% | 9,870 | +1.8% | 0.00% | 0.0% |
| Q1 2015 | $212,000 | – | 9,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $54,577,000 | 41.39% |
| Discovery Group I, LLC | 2,089,974 | $38,581,000 | 14.72% |
| Essex Woodlands Management, Inc. | 3,231,656 | $59,656,000 | 10.58% |
| Archon Capital Management LLC | 550,224 | $10,157,000 | 5.46% |
| First Light Asset Management, LLC | 632,737 | $11,680,000 | 3.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $6,303,000 | 2.45% |
| Ghost Tree Capital, LLC | 561,510 | $10,365,000 | 2.20% |
| Aisling Capital LLC | 528,655 | $9,759,000 | 1.60% |
| Cypress Capital Management LLC (WY) | 66,965 | $1,236,000 | 1.46% |
| Endurant Capital Management LP | 208,771 | $3,854,000 | 1.17% |